'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Video Credit: ANI
Published on March 3, 2021 - Duration: 01:42s

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial.

"Today is an important day for us, country and Indian science.

COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial.

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.

You are here

๐Ÿ’ก newsR Knowledge: Other News Mentions


Vaccine against COVID-19
The PMโ€™s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
Credit: IndiaTimes - Published 10 hours ago

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
Credit: DNA - Published 2 days ago

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
Credit: IndiaTimes - Published 2 days ago


Disease caused by severe acute respiratory syndrome coronavirus 2
Congress leader Rahul Gandhi on Sunday suspended his campaign for the West Bengal assembly elections owing to the prevailing Covid-19 situation in the country.
Credit: IndiaTimes - Published 8 minutes ago

India on Sunday recorded another highest-ever spike of 2,61,500 coronavirus infections, taking its total Covid-19 cases tally to 1,47,88,109. India also reported..
Credit: IndiaTimes - Published 1 hour ago

Credit: IndiaTimes - Published 2 hours ago

Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Indications are that Indiaโ€™s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
Credit: IndiaTimes - Published 1 week ago

Related news from verified sources

Bharat Biotech announced the phase 3 results of its coronavirus vaccine โ€˜Covaxinโ€™on Wednesday claiming the shots have demonstrated an interim clinical...
on March 3, 2021 • Zee News

prestigious medical journal The Lancet has now published Phase 2 clinical trial results of Bharat Biotech's Covaxin. "Due to the difference in dosing regimens...
on March 9, 2021 • IndiaTimes

Related videos from verified sources

Nurses share experience after administering COVID vaccine to PM Modi 01:16
Video credit: ANI - Published 1 week ago 

Phase 3 Clinical Trial Of Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months 02:26
Video credit: CBS4 Miami - Published 2 weeks ago 

Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months 01:00
Video credit: Cover Video STUDIO - Published 2 weeks ago 

You might like